Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
3SBio (HK:1530)
HKEX:1530
Holding HK:1530?
Track your performance easily
1530 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$4.91 - HK$7.85
Previous CloseHK$6.08
Volume11.03M
Average Volume (3M)8.93M
Market Cap
HK$14.57B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)8.1
Beta0.86
Next Earnings
Mar 19, 2025EPS Estimate
HK$0.38Last Dividend Ex-Date
Jul 22, 2024Dividend Yield4.08%
Share Statistics
EPS (TTM)0.74
Shares OutstandingN/A
10 Day Avg. Volume10,716,732
30 Day Avg. Volume8,932,335
Standard Deviation0.13
R-Squared0.20
Alpha-0.00484
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)2.80
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$8.70Price Target Upside43.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
3SBio News
PremiumCompany Announcements
3SBio Secures Exclusive Rights for Cancer Drug
PremiumCompany Announcements
3SBio Issues Supplemental Share Grant Info
PremiumCompany Announcements
3SBio Awards Shares to Top Performers
PremiumCompany Announcements
3SBio Reports Strong Growth in H1 2024
PremiumCompany Announcements
3SBio Inc. to Review H1 2024 Financials and Dividend
PremiumCompany Announcements
3SBio Inc. AGM Concludes with Key Resolutions PassedPremiumCompany Announcements
3SBio Inc. Announces Board Composition DetailsPremiumCompany Announcements
3SBio Subsidiary Strikes Key Weight Management Drug DealOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.49% Mutual Funds
― Other Institutional Investors
93.28% Public Companies and
Individual Investors
1530 FAQ
What was 3SBio’s price range in the past 12 months?
3SBio lowest stock price was HK$4.91 and its highest was HK$7.85 in the past 12 months.
What is 3SBio’s market cap?
Currently, no data Available
When is 3SBio’s upcoming earnings report date?
3SBio’s upcoming earnings report date is Mar 19, 2025 which is in 129 days.
How were 3SBio’s earnings last quarter?
3SBio released its earnings results on Aug 22, 2024. The company reported HK$0.487 earnings per share for the quarter, beating the consensus estimate of HK$0.476 by HK$0.011.
Is 3SBio overvalued?
According to Wall Street analysts 3SBio’s price is currently Undervalued.
Does 3SBio pay dividends?
3SBio pays a Annually dividend of HK$0.25 which represents an annual dividend yield of 4.08%. See more information on 3SBio dividends here
What is 3SBio’s EPS estimate?
3SBio’s EPS estimate is HK$0.38.
How many shares outstanding does 3SBio have?
3SBio has 2,416,801,000 shares outstanding.
What happened to 3SBio’s price movement after its last earnings report?
3SBio reported an EPS of HK$0.487 in its last earnings report, beating expectations of HK$0.476. Following the earnings report the stock price went down -0.466%.
Which hedge fund is a major shareholder of 3SBio?
Currently, no hedge funds are holding shares in HK:1530
---
3SBio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.12%
12-Months-Change
Fundamentals
Return on Equity
11.96%
Trailing 12-Months
Asset Growth
3.32%
Trailing 12-Months
Company Description
3SBio
3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products. It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
---
1530 Stock 12 Month Forecast
Average Price Target
HK$8.70
▲(43.16% Upside)
Technical Analysis
3SBio
―
Achieve Life Sciences
―
Aldeyra Therapeutics
―
Aileron Therapeutics
―
Armata Pharmaceuticals
―
Best Analysts Covering 1530
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+3.20%
reiterated a buy rating 3 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +3.20% per trade.
---